Stanford Medicine News

Precision Health

Read about Stanford Medicine's vision for leading the biomedical revolution.

Donor e-newsletter

This quarterly e-newsletter highlights Stanford Medicine news and events.

Planning for the Future

The latest planned giving newsletter was mailed November 2015.

  • Wearable sensors can tell when you are getting sick

    New research from Stanford professor and chair of genetics, Michael Snyder, PhD shows that fitness monitors and other wearable biosensors can tell when an individual’s heart rate, skin temperature and other measures are abnormal, suggesting possible illness before it occurs. The results of Snyder’s current study raises the possibility of identifying inflammatory disease in individuals who may not even know they are getting sick.

  • Deep-learning algorithm matches dermatologists’ ability to identify skin cancer

    Universal access to health care was on the minds of computer scientists at Stanford when they set out to create an artificially intelligent diagnosis algorithm for skin cancer. They created a database of nearly 130,000 skin disease images and trained the algorithm to visually diagnose potential cancer. From the very first test, it performed with inspiring accuracy.

  • 5 Questions: David Entwistle on taking the helm of SHC

    In a Q&A, the new president and CEO of Stanford Health Care shares his thoughts about his new job and the evolving health care landscape.

  • Stanford part of Bay Area Biohub collaboration for health research

    Stanford will be one of three Bay Area universities — along with the University of California-San Francisco and the University of California-Berkeley — to participate in a new bioscience collaboration funded through a $600 million commitment by the Chan Zuckerberg Initiative.

  • Stanford Cancer Institute Earns Top Cancer Center Designation

    The Stanford Cancer Institute has been designated a Comprehensive Cancer Center by the National Cancer Institute, a part of the National Institutes of Health and the world’s leading cancer research organization.

  • Parker Institute for Cancer Immunotherapy

    The new Parker Institute for Cancer Immunotherapy at Stanford Medicine was founded with a $250 million grant from the Parker Foundation. Learn more about their work.

  • Stanford Medicine, Google team up to harness power of data science for health care

    Stanford Medicine will use the power, security and scale of Google Cloud Platform to support precision health and more efficient patient care.

  • Professors Elected to National Academy of Sciences

    School of Medicine faculty members Helen Blau, PhD, and John Boothroyd, PhD, have been elected to the National Academy of Sciences.

  • Carla Shatz Wins Kavli Neuroscience Prize

    Carla Shatz, PhD, professor of neurobiology and of biology at Stanford, has won the 2016 Kavli Neuroscience Prize for her work in understanding how the brain’s wiring takes shape during development.

  • Vantage Point: We don't just need precision medicine, we need precision health

    The dean of the School of Medicine hopes the country’s leaders will set their sights higher in their quest to improve the health of the American people.

  • Byerwalter to Serve as Interim President of Stanford Health Care

    Mariann Byerwalter will serve as interim president and CEO of Stanford Health Care beginning Jan. 2. To ensure a smooth changeover, she will transition into her new role over the final two months of current president and CEO Amir Dan Rubin’s tenure.

  • Neuroscience Health Center

    Stanford Neuroscience Health Center for neurological injuries, brain tumors, movement disorders, brain aneurysms, spine deterioration, Parkinson’s & memory disorders.

  • Roberts Earns Top Ethics Prize

    Imagine being terrified you might kill yourself. Then imagine driving 300 miles to the nearest city for psychiatric care because you’re even more afraid someone in your town will find out about your depression. Or worse yet, being so afraid of being labeled “crazy” that you don’t seek care at all.

  • Closing In on Cancer

    Edgar Engleman's lab gives the immune system 'a little kick in the butt,' to stunning effect.

  • 5 Questions: Euan Ashley on diagnosing the undiagnosable

    The National Institutes of Health’s Undiagnosed Diseases Network launches today, and Euan Ashley, MRCP, DPhil, associate professor of cardiovascular medicine and of genetics at the Stanford University School of Medicine, has been named co-chair of the UDN steering committee.

  • Photovoltaic retinal implant could restore functional sight, researchers say

    A Stanford cardiac electrophysiologist and colleagues have used a unique research method to learn more about atrial fibrillation. Mintu Turakhia, MD, and collaborators at Medtronic and Massachusetts General Hospital, extracted data out of decades of continuously recorded medical information from implanted medical devices—pacemakers and defibrillators—in 10,000 heart patients. Then they linked it to medical records, and analyzed it.

  • Stanford-based Alzheimer’s Disease Research Center to be launched

    The National Institutes of Health will fund the establishment of an Alzheimer’s Disease Research Center at the Stanford University School of Medicine. The award, totaling slightly more than $7.3 million, will be dispensed over a five-year period.

  • Combination drug therapy shrinks pancreatic tumors in mice

    A combination of two drugs, one already approved by the Food and Drug Administration, appears to be effective at shrinking pancreatic cancers in laboratory mice, according to a new study by researchers at the Stanford University School of Medicine.

  • Stanford launches smartphone app to study heart health

    A free iPhone app allows users to contribute to a study of human heart health while learning about the health of their own hearts, and uses a new software framework developed by Apple.

  • Photovoltaic retinal implant could restore functional sight, researchers say

    A team led by Stanford University researchers has developed a wireless retinal implant that they say could restore vision five times better than existing devices.